Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Pullarkat, Vinod A, Lacayo, Norman J, Jabbour, Elias, Rubnitz, Jeffrey E, Bajel, Ashish, Laetsch, Theodore W, Leonard, Jessica, Colace, Susan I, Khaw, Seong Lin, Fleming, Shaun A, Mattison, Ryan J, Norris, Robin, Opferman, Joseph T, Roberts, Kathryn G, Zhao, Yaqi, Qu, Chunxu, Badawi, Mohamed, Schmidt, Michelle, Tong, Bo, Pesko, John C, Sun, Yan, Ross, Jeremy A, Vishwamitra, Deeksha, Rosenwinkel, Lindsey, Kim, Su Young, Jacobson, Amanda, Mullighan, Charles G, Alexander, Thomas B, Stock, Wendy
Published in Cancer discovery (01.06.2021)
Published in Cancer discovery (01.06.2021)
Get full text
Journal Article
CD34 Chimerism Directed Donor Lymphocyte Infusion With or Without Azacitidine Results in Reduced Relapse and Superior Overall Survival When Full Donor Chimerism is Achieved in Allogeneic Stem Cell Transplant Recipients With Acute Myeloid Leukaemia/Myelodysplastic Syndrome
Tan, Joanne LC, Curtis, David J, Muirhead, Jenny, Swain, Michael I, Fleming, Shaun A, Cirone, Bianca, O'Brien, Maureen E, Wong, Shu M, Inam, Shafqat, Patil, Sushrut, Spencer, Andrew
Published in Clinical lymphoma, myeloma and leukemia (01.11.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.11.2024)
Get full text
Journal Article
Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
Das, Tongted P., North, Daniel, Fleming, Shaun A., Tan, Joanne L.C., Ivey, Adam, Cummings, Nicholas J., Spencer, Andrew, Patil, Sushrut S., Widjaja, Jacqueline M.L., Swain, Michael I., Bourke, Catherine, O'Brien, Maureen E., Kliman, David S., Curtis, David J.
Published in Transplantation and cellular therapy (01.07.2023)
Published in Transplantation and cellular therapy (01.07.2023)
Get full text
Journal Article
POSTER: CT-526 Updated Results From a Rapcabtagene Autoleucel (YTB323) Phase I Study Demonstrate Durable Efficacy and a Manageable Safety Profile in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Shah, Nirav N., Flinn, Ian, Kwon, Mi, Jäger, Ulrich, Briones, Javier, Bachy, Emmanuel, Blaise, Didier, Boissel, Nicolas, Kato, Koji, Riedell, Peter A., Frigault, Matthew J., Shune, Leyla O., Teshima, Takanori, Ciceri, Fabio, Fleming, Shaun A., Ferrari, Silvia, Pearson, David, Whalen, Jeanne, Zia, Aiesha, Davis, Jaclyn, Masood, Aisha, Dickinson, Michael, Barba, Pere
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article
CT-526 Updated Results From a Rapcabtagene Autoleucel (YTB323) Phase I Study Demonstrate Durable Efficacy and a Manageable Safety Profile in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Shah, Nirav N., Flinn, Ian, Kwon, Mi, Jäger, Ulrich, Briones, Javier, Bachy, Emmanuel, Blaise, Didier, Boissel, Nicolas, Kato, Koji, Riedell, Peter A., Frigault, Matthew J., Shune, Leyla O., Teshima, Takanori, Ciceri, Fabio, Fleming, Shaun A., Ferrari, Silvia, Pearson, David, Whalen, Jeanne, Zia, Aiesha, Davis, Jaclyn, Masood, Aisha, Dickinson, Michael, Barba, Pere
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2023)
Get full text
Journal Article